Contract research organizations make good money providing critical services to young biotech and drug development companies early on. But often, those companies are cash-strapped at the stage when they need a CRO. That’s why some CROs are becoming stakeholders in the companies they work with, offering cash or services for equity in life science startups. […]
Elizabeth Iorns, co-founder and CEO of Science Exchange, created an online marketplace for researchers to solve her own problem. At the time she was an Assistant Professor at the University of Miami Miller School of Medicine. “My research hit a roadblock every time I needed to conduct experiments that were outside my field of expertise,” […]
After Medtronic‘s (MDT) January announcement it’s halting renal denervation trials and BSX and Covidien following suit, the medical blogosphere erupted, proclaiming the “fall” of renal denervation. It seems to be more than a little premature, considering there are other forms of renal denervation than RF (such as ReCor‘s ultrasound method) and other potential uses than for hypertension. […]
It’s no secret pharmaceutical companies are outsourcing more and more work to clinical research organizations. But when it comes to recruiting doctors to run the studies, they’re not happy at all. In fact, many pharma companies would prefer to do that work themselves. If given the option, nearly half of pharmaceutical companies surveyed by research […]
Clinical research organization Inclinix is merging with PMG Research in the latest merger and acquisition deal to hit the CRO space. Inclinix provides clinical trial recruitment services for pharmaceutical, biotechnology and medical device companies. PMG Research operates a network of clinical research sites to run clinical trials in the Southeast United States. The merger was […]
Clinical research organization PPD has hired a Pfizer (NYSE:PFE) veteran to become its new CEO. David Simmons brings 15 years experience at the world’s largest pharmaceutical company to PPD, which is one of the largest CROs in the pharmaceutical services industry. The CEO post became vacant after PPD was taken private in a $3.9 billion […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Pharmaceutical companies and insurers are still figuring out how they’ll work with each other, but a clear majority of both camps surveyed in Quintiles‘ annual New Health Report expect that there will be more collaborations in the future. The survey included more than 1,350 healthcare stakeholders ranging from healthcare payers, executives, patients and investors in […]
The clinical trials process is becoming more of an electronic endeavor as the proliferation of data sparks new software to efficiently manage it. But one aspect of these studies has remained manual and slow: payment to the doctors who run the studies. Clinical trials technology company Clinverse has developed cloud-based software that overcomes the payment […]
Amgen‘s (NASDAQ:AMGN) biosimilar drug portfolio will be studied in clinical trials in alliance with clinical research organization PRA. PRA has entered into a strategic partnership with Amgen to do work on a series of phase 3 studies to develop biosimilar drugs. Biosimilars are follow-on biologic drugs that are cheaper than very expensive biologic drugs. No […]
Cetero Research, the clinical research organization that fell under a U.S. Food and Drug Administration probe for allegedly falsifying clinical trial records, has reached a “final resolution” with regulators about which studies can stand and which ones must be redone. The FDA had raised questions about data from Cetero’s Houston bioanalytical laboratory over a five-year […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Dennis Gillings doesn’t give many interviews and today, the day his Quintiles successor was announced, he wasn’t available to talk either. I’ve had a few occasions to talk with Gillings and our most recent exchange happened after a life sciences conference in North Carolina a few years ago. By chance, we both left the […]
Quintiles‘ new CEO Tom Pike brings to the clinical research organization nearly 30 years experience — but none of that time was spent at a CRO or a pharmaceutical company. Pike spent 22 years at management consulting firm Accenture (NYSE:ACN). He was named today the successor to Dennis Gillings, who has led Quintiles since he […]
Quintiles CEO Dennis Gillings is stepping away from the top post of the company he founded and built into the largest clinical research organization in the industry. Tom Pike, a 22-year veteran of management consultant company Accenture, has been appointed Quintiles’ new CEO. Pike will join the Durham, North Carolina-based CRO on April 30. Gillings […]
Cardiovascular medical devices clinical research organization genae has hired a new chief medical officer. The CRO, which is based in Belgium and last year established a U.S. headquarters in Cleveland, has hired Dr. Catalina Trana for the role, according to a statement. Trana’s responsibilities will include all clinical, safety and risk management related to genae’s […]
Cetero Research‘s unsecured creditors will have a little more time to prepare a bid to buy the bankrupt clinical research organization. The bankruptcy court has extended the bid deadline for the CRO by 11 days to May 11, Outsourcing Pharma, reported. Unsecured creditors of Cetero last week asked the court for an extension, claiming the […]
